PEDIATRICS Vol. 70 No. 3 September 1982, pp. 370-375
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szefler, S. J.
Right arrow Articles by Shen, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szefler, S. J.
Right arrow Articles by Shen, D. D.

Rapid Elimination of Quinidine in Pediatric Patients

Stanley J. Szefler MD1, Daniel R. Pieroni MD1, Robert L. Gingell MD1, and Danny D. Shen PhD1

1 Departments of Pediatrics, Pharmacology and Therapeutics, and Pharmaceutics, Schools of Medicine and Pharmacy, State University of New York at Buffalo and Childre's Hospital of Buffalo, Buffalo

The oral absorption and elimination of quinidine in pediatric patients was studied. Single oral doses of quinidine sulfate were administered to 13 patients ranging in age from 4 to 22 years of age. Serum quinidine concentration reached a peak within 30 minutes to two hours after drug administration. The serum half-life of quinidine varied from 2.5 to 6.7 hours and was, on the average, shorter than the reported estimates for adult volunteers and cardiac patients (means ranging from 4.9 to 7.3 hours). Hence, more frequent dosing or the use of slow-release preparations may be necessary in some pediatric patients in order to avoid excessive fluctuation in serum drug concentrations over a dosage interval. The oral dose clearance of quinidine (ie, oral dose divided by the area under the serum concentration time curve) varied over a threefold range, from 0.151 to 0.570 liter/hr/kg, and was found to correlate inversely with age (r = .80). In comparison with mean clearance estimates that have been reported for normal adult volunteers (0.293 ± 0.078 liter/hr/kg), children less than 12 years of age (0.461 ± 0.117 liter/hr/kg) were found to have significantly higher clearances, whereas no difference was observed between older children (0.287 ± 0.101 liter/hr/kg) and adults. Inasmuch as the average steady-state serum drug concentration for a given daily maintenance dose is directly related to clearance rate, children less than 12 years of age may require a higher dosage of quinidine on a per kilogram of body weight basis. Proper selection of quinidine dosage, careful adjustment of dosage according to age, and regular monitoring of drug response and serum drug concentration are essential steps to a rational management of quinidine therapy in children.

Submitted on June 8, 1981
Accepted on September 3, 1981




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
J. G. Blanco, P. L. Harrison, W. E. Evans, and M. V. Relling
Human Cytochrome P450 Maximal Activities In Pediatric versus Adult Liver
Drug Metab. Dispos., April 1, 2000; 28(4): 379 - 382.
[Abstract] [Full Text]